Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

Nicola Curry, Canan Albayrak, Miguel Escobar, Pål Andre Holme, Susan Kearney, Robert Klamroth, Mudi Misgav, Claude Négrier, Allison Wheeler, Elena Santagostino, Midori Shima, Andrea Landorph, Sidsel Marie Tønder, Steven R. Lentz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences